JOURNAL OF CARDIOVASCULAR MEDICINE, cilt.16, sa.9, ss.603-609, 2015 (SCI-Expanded)
Background Ivabradine is a heart rate (HR)-lowering agent acting by inhibiting the I-f-channel. Dobutamine does increase the HR and has some deleterious effects on myocardium. So, we aimed to evaluate whether ivabradine treatment blunts a dobutamine-induced increase in HR.